Paper37656172
The myth of brain damage: no change of neurofilament light chain during transient cognitive side-effects of ECT.
Besse M and 5 others. Eur Arch Psychiatry Clin Neurosci, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The myth of brain damage: no change of neurofilament light chain during transient cognitive side-effects of ECT. Papers, record 37656172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37656172
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The myth of brain damage: no change of neurofilament light chain during transient cognitive side-effects of ECT.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neurofilament Proteins | Major topic |
| Electroconvulsive Therapy | Major topic |
| Major Depressive Disorder | Major topic |
| Neuropsychological Tests | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| Aged | |
| Cognition Disorders | |
| Biomarkers |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31818180 | Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy. | World J Biol Psychiatry | 2020 | https://conductscience.org/library/papers/31818180 | PubMed |
| 2 | 36201960 | Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors. | J Neurol Sci | 2022 | https://conductscience.org/library/papers/36201960 | PubMed |
| 3 | 27819296 | Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. | Sci Rep | 2016 | https://conductscience.org/library/papers/27819296 | PubMed |
| 4 | 30626580 | Should we stop using electroconvulsive therapy? | BMJ | 2019 | https://conductscience.org/library/papers/30626580 | PubMed |
| 5 | 31801966 | Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. | Mol Psychiatry | 2020 | https://conductscience.org/library/papers/31801966 | PubMed |
| 6 | 34274106 | The Neurobiological Effects of Electroconvulsive Therapy Studied Through Magnetic Resonance: What Have We Learned, and Where Do We Go? | Biol Psychiatry | 2022 | https://conductscience.org/library/papers/34274106 | PubMed |
| 7 | 12446263 | Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage. | Am J Epidemiol | 2002 | https://conductscience.org/library/papers/12446263 | PubMed |
| 8 | 20673880 | Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. | Biol Psychiatry | 2010 | https://conductscience.org/library/papers/20673880 | PubMed |
| 9 | 28404801 | Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. | Neurology | 2017 | https://conductscience.org/library/papers/28404801 | PubMed |
| 10 | 36077033 | Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077033 | PubMed |
| 11 | 36130459 | Serum neurofilament levels in patients with multiple sclerosis: A comparison of SIMOA and high sensitivity ELISA assays and contributing factors to ELISA levels. | Mult Scler Relat Disord | 2022 | https://conductscience.org/library/papers/36130459 | PubMed |
| 12 | 35172057 | Electroconvulsive Therapy. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35172057 | PubMed |
| 13 | 29149717 | Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy. | Psychiatry Res | 2018 | https://conductscience.org/library/papers/29149717 | PubMed |
| 14 | 32730916 | Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression. | Prog Neuropsychopharmacol Biol Psychiatry | 2021 | https://conductscience.org/library/papers/32730916 | PubMed |
| 15 | 11511718 | Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. | J Neurol Neurosurg Psychiatry | 2001 | https://conductscience.org/library/papers/11511718 | PubMed |
| 16 | 27876183 | Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study. | Eur Neuropsychopharmacol | 2016 | https://conductscience.org/library/papers/27876183 | PubMed |
| 17 | 35944604 | Multimodal multi-center analysis of electroconvulsive therapy effects in depression: Brainwide gray matter increase without functional changes. | Brain Stimul | 2022 | https://conductscience.org/library/papers/35944604 | PubMed |
| 18 | 24801966 | Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression. | J Neural Transm (Vienna) | 2014 | https://conductscience.org/library/papers/24801966 | PubMed |
| 19 | 8010381 | Does ECT alter brain structure? | Am J Psychiatry | 1994 | https://conductscience.org/library/papers/8010381 | PubMed |
| 20 | 32895922 | Cognitive change after electroconvulsive therapy in mood disorders measured with the Montreal Cognitive Assessment. | Acta Psychiatr Scand | 2020 | https://conductscience.org/library/papers/32895922 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649424 | ECT is not an invasive therapy. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42649424 | PubMed |
| 40054874 | Investigating the impact of electroconvulsive therapy on brain networks and sleep: an observational study protocol. | BMJ Open | 2025 | https://conductscience.org/library/papers/40054874 | PubMed |
| 39363047 | Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/39363047 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37656172
GET https://conductscience.org/api/papers/v1/37656172/references?page=2